Arrowhead Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
CEOChristopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees609
Employees609
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1989
Founded1989
Employees609
Employees609
ARWR Key Statistics
Market cap2.20B
Market cap2.20B
Price-Earnings ratio-11.56
Price-Earnings ratio-11.56
Dividend yield—
Dividend yield—
Average volume2.48M
Average volume2.48M
High today$16.00
High today$16.00
Low today$15.49
Low today$15.49
Open price$15.49
Open price$15.49
Volume1.48M
Volume1.48M
52 Week high$27.34
52 Week high$27.34
52 Week low$9.57
52 Week low$9.57
ARWR News
Seeking Alpha 5d
Arrowhead Pharmaceuticals earns $100M milestone from Sarepta TherapeuticsArrowhead Pharmaceuticals (NASDAQ:ARWR) Monday announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The miles...
Analyst ratings
67%
of 15 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.